Premium
SYNERGISTIC EFFECTS OF ANTIVIRAL AGENTS AND HUMORAL ANTIBODIES IN EXPERIMENTAL HERPESVIRUS HOMINIS ENCEPHALITIS
Author(s) -
Cho C. T.,
Feng K. K.
Publication year - 1977
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1977.tb21967.x
Subject(s) - virology , herpesvirus hominis , antibody , encephalitis , medicine , immunology , virus , herpesviridae , viral disease
Experimental Herpesvirus hominis encephalitis in 3-week-old Swiss mice was utilized to evaluate the antiviral effects of adenine arabinoside (ara-A), phosphonacetic acid (PAA), and humoral antibodies to H. hominis (HIG). Administration of ara-A, PAA, or HIG during the early phase of infection reduced the mortality rate of H. hominis encephalitis in mice. Combined administration of humoral antibodies with an antiviral agent (ara-A or PAA) resulted in an enhanced protection, accompanied by a decreased virus concentration in the brain tissues and a diminished tissue injury. The generality of this enhancing effect of humoral antibodies on the action of antiviral agents and its possible use in therapy of viral infections warrant further investigation.